Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Cancer|September 15, 1989
Interleukin-2 enhances biopterins and catecholamines production during adoptive immunotherapy for various cancersH Baker, S L Marcus, O Frank, et al.Lasers in Medical Science|February 13, 2014
The Monitoring of ALA-Induced Protoporphyrin IX Accumulation and Clearance in Patients with Skin Lesions by In Vivo Surface-Detected Fluorescence SpectroscopyA L Golub, E F Gudgin Dickson, J C Kennedy, et al.Molecular and Cellular Endocrinology|June 1, 1995
Calreticulin modulates the in vitro DNA binding but not the in vivo transcriptional activation by peroxisome proliferator-activated receptor/retinoid X receptor heterodimersC J Winrow, K S Miyata, S L Marcus, et al.Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenaseB Zhang, S L Marcus, F G Sajjadi, et al.Journal of the American College of Nutrition|October 1, 1992
Effect of interleukin-2 on some micronutrients during adoptive immunotherapy for various cancersH Baker, S L Marcus, D P Petrylak, et al.The Journal of Biological Chemistry|September 9, 2000
Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigDO Steele-Mortimer, L A Knodler, S L Marcus, et al.Journal of the Society for Gynecologic Investigation|April 29, 2000
Photodynamic endometrial ablation in the nonhuman primateD A Van Vugt, A Krzemien, B N Roy, et al.Cancer Research|August 1, 1987
Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, J P Dutcher, E Paietta, et al.Gut|October 18, 2000
Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trialR Ackroyd, N J Brown, M F Davis, et al.The American Journal of Clinical Nutrition|December 1, 1991
Hypovitaminosis C in patients treated with high-dose interleukin 2 and lymphokine-activated killer cellsS L Marcus, D P Petrylak, J P Dutcher, et al.Pageof 15